INDmoney
Abbvie Inc Stock Performance
as on March 6, 2026 at 7:59 am IST
Day's Low
Day's High
$228.09$234.80
1.82%
Downside
1.07%
Upside
52 Week's Low
52 Week's High
$164.39$244.8129.24%
Downside
5.38%
Upside
Abbvie Inc share price movements today
- Previous Close
- $236.19
- Open
- $233.70
- Volume
- 6.8M
- Day's Low - High
- $228.09 - $234.80
- 52 Week Low - High
- $164.39 - $244.81
Abbvie Inc Historical Returns
- 1 Month Return
- + 7.84 %
- 3 Month Return
- + 4.47 %
- 1 Year Return
- + 11.65 %
- 3 Year Return
- + 51.35 %
- 5 Year Return
- + 121.36 %
Abbvie Inc Stock Fundamentals & Key Indicators
Check Abbvie Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$413.5B
EPS (TTM)
14.5307
Dividend Yield
3.10%
Quarterly Earnings Growth YOY
-0.89%
PE Ratio (TTM)
99.09
Industry PE ratio
19.52111111111111
PEG Ratio
0.5554
EBITDA
29.3B
Revenue (TTM)
61.2B
Profit Margin
6.91%
Return On Equity TTM
62.25%
Abbvie Inc Stock Valuation
Track how Abbvie Inc P/E has moved over time to understand its valuation trends.
Abbvie Inc in the last 5 years
Lowest (9.30x)
September 30, 2021
Industry (19.52x)
March 5, 2026
Today (99.09x)
March 5, 2026
Highest (22.78x)
December 31, 2025
Today’s Price to Earnings Ratio: 99.09x
Abbvie Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Abbvie Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $413.5B | 121.36% | 99.09 | 6.91% | |
| BUY | $901.9B | 385% | 44.45 | 31.67% | |
| BUY | $312.8B | 319.33% | 30.85 | 17.41% | |
| BUY | $594.6B | 57.14% | 22.37 | 28.46% | |
| BUY | $296.3B | 64.47% | 16.44 | 28.08% |
Stock Returns calculator for Abbvie Inc Stock including INR - Dollar returns
The Abbvie Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Abbvie Inc investment value today
Current value as on today
₹1,15,196
Returns
₹15,196
(+15.2%)
Returns from Abbvie Inc Stock
₹9,823 (+9.82%)
Dollar Returns*
₹5,372 (+5.37%)
Analyst Recommendation on Abbvie Inc Stock
Based on 35 analysts
65.71%
Buy
34.29%
Hold
0.00%
Sell
Based on 35 analysts, 65.71% of analysts recommend a 'BUY' rating for Abbvie Inc. Average target price of $248.69
Abbvie Inc Share Price Target
Get share price movements and forecasts by analysts on Abbvie Inc.
What analysts predicted
6.58%UPSIDE
Target Price
$248.69
Current Price
$232.32
Analyzed by
35 Analysts
Target
$248.69
Abbvie Inc target price $248.69, a slight upside of 6.58% compared to current price of $232.32. According to 35 analysts rating.
Abbvie Inc Stock’s Investor Sentiment and Interest
Investment in Abbvie Inc Shares on INDmoney has dropped by -30.66% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Abbvie Inc Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Abbvie Inc Quarterly Profit & Loss
All numbers in Millions USD
Abbvie Inc Annual Profit & Loss
All numbers in Millions USD
Abbvie Inc Quarterly Cash Flow
All numbers in Millions USD
Abbvie Inc Annual Cash Flow
All numbers in Millions USD
Mutual Funds that own Abbvie Inc Stock
Check out the Mutual Funds with significant holdings in Abbvie Inc.
Funds | Holdings | Shares Held |
|---|---|---|
 Motilal Oswal S&P 500 Index Fund Direct Growth | 0.64365% | 13304 |
 Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth | 2.96154% | 2411 |
Global Institutional Holdings in Abbvie Inc
Abbvie Inc News & Key Events
Today's Timeline - 02 March
Mon, 01:27 PM
-AbbVie plans to invest $380 million in new manufacturing facilities integrating AI for next-gen medications.
Mon, 07:00 PM
-AbbVie announces positive Phase 3 results for risankizumab in Crohn's disease, showing significant efficacy.
Tue, 06:36 AM
-AbbVie receives FDA approval for oral combination therapy for chronic lymphocytic leukemia, enhancing its oncology portfolio.
Insights on Abbvie Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Abbvie Inc has shown impressive growth in its net profit over the last two quarters. It increased from $186.0 million to $1.81 billion, which translates to an average quarterly growth rate of 89.8%. This indicates strong financial performance and positive trends in profitability for the company.
- POSITIVE IMPACT
Revenue Rich
Abbvie Inc has shown consistent revenue growth over the last four quarters. The company's revenue increased from $13.34 billion to $16.61 billion, reflecting an average growth rate of 6.9% per quarter.
- POSITIVE IMPACT
Price Rise
In the last 7 days, ABBV stock has moved up by 5.1%
NO EFFECTAgainst Peers
In the last 3 years, Eli Lilly And Company has given 209.1% return, outperforming this stock by 157.8%
- NO EFFECT
Against Peers
In the last 1 year, ASTRAZENECA PLC has given 158.5% return, outperforming this stock by 146.8%
About Abbvie Inc
| Organisation | Abbvie Inc |
| Headquarters | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 |
| Industry | Health Technology |
| CEO | Mr. Robert A. Michael CPA |
| E-voting on shares | Click here to vote |
Key Management of Abbvie Inc
Name | Title |
|---|---|
Dr. Azita Saleki-Gerhardt Ph.D. | Executive VP & COO |
Mr. Jeffrey Ryan Stewart | Executive VP & Chief Commercial Officer |
Ms. Elizabeth Shea | Senior Vice President of Investor Relations |
Mr. Perry C. Siatis | Executive VP, General Counsel & Secretary |
Mr. Robert A. Michael CPA | CEO & Chairman of the Board |
Mr. Scott T. Reents | Executive VP & CFO |
Mr. Wulff-Erik von Borcke | Senior VP & President of Oncology |
Dr. Nicholas J. Donoghoe M.D. | Executive VP and Chief Business & Strategy Officer |
Dr. Roopal Thakkar M.D. | Executive VP of Research & Development and Chief Scientific Officer |
Mr. Demetris D. Crum | Executive VP & Chief Human Resources Officer |
FAQs
What is Abbvie Inc share price today?
Abbvie Inc share price today is $232.32 as on at the close of the market. Abbvie Inc share today touched a day high of $234.8 and a low of $228.09.
What is the 52 week high and 52 week low for Abbvie Inc share?
Abbvie Inc share touched a 52 week high of $244.81 on and a 52 week low of $164.39 on . Abbvie Inc stock price today i.e. is closed at $232.32,which is 5.10% down from its 52 week high and 41.32% up from its 52 week low.
What is Abbvie Inc's market capitalisation today?
Abbvie Inc market capitalisation is $0.41T as on .
How to invest in Abbvie Inc Stock (ABBV) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Abbvie Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Abbvie Inc Shares that will get you 0.0065 shares as per Abbvie Inc share price of $232.32 per share as on March 6, 2026 at 2:29 am IST.
What is the minimum amount required to buy Abbvie Inc Stock (ABBV) from India?
Indian investors can start investing in Abbvie Inc (ABBV) shares with as little as ₹91.558 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹915.58 in Abbvie Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Abbvie Inc share’s latest price of $232.32 as on March 6, 2026 at 2:29 am IST, you will get 0.0430 shares of Abbvie Inc. Learn more about
fractional shares .
What are the returns that Abbvie Inc has given to Indian investors in the last 5 years?
Abbvie Inc stock has given 121.36% share price returns and 25.13% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?